| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |